51 |
Unimed Pharmaceuticals LLC et al v. Lupin Atlantis Holdings SA et al |
1:15-cv-00904 |
D.Del. |
|
|
|
|
52 |
ELI LILLY AND COMPANY et al v. LUPIN PHARMACEUTICALS, INC et al |
1:15-cv-01047 |
S.D.Ind. |
|
|
|
|
53 |
ELI LILLY AND COMPANY et al v. LUPIN PHARMACEUTICALS, INC et al |
1:15-cv-01047 |
S.D.Ind. |
|
|
|
|
54 |
ELI LILLY AND COMPANY et al v. LUPIN PHARMACEUTICALS, INC et al |
1:15-cv-01047 |
S.D.Ind. |
|
|
|
|
55 |
Vanda Pharmaceuticals Inc. v. Lupin Limited et al |
1:15-cv-01073 |
D.Del. |
|
|
|
|
56 |
Alcon Research, Ltd. v. Watson Laboratories, Inc., et al., |
1:15-cv-01159 |
D.Del. |
|
|
|
|
57 |
Merck & CIE et al v. Lupin Ltd. et al |
1:15-cv-01472 |
D.Md. |
|
|
|
|
58 |
Merck & CIE et al v. Lupin Ltd. et al |
1:15-cv-01472 |
D.Md. |
|
|
|
|
59 |
Merck & CIE et al v. Lupin Ltd. et al |
1:15-cv-01472 |
D.Md. |
|
|
|
|
60 |
HORIZON PHARMA IRELAND LIMITED et al v. LUPIN LTD. et al |
1:15-cv-06935 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
61 |
HORIZON PHARMA IRELAND LIMITED et al v. LUPIN LTD. et al |
1:15-cv-06935 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
62 |
HORIZON PHARMA IRELAND LIMITED et al v. LUPIN LTD. et al |
1:15-cv-06935 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
63 |
Shire Development LLC et al v. Lupin Limited et al |
1:16-cv-00612 |
D.Md. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
64 |
Shire Development LLC et al v. Lupin Limited et al |
1:16-cv-00612 |
D.Md. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
65 |
Shire Development LLC et al v. Lupin Limited et al |
1:16-cv-00612 |
D.Md. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
66 |
Shire Development LLC et al v. Lupin Limited et al |
1:16-cv-00612 |
D.Md. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
67 |
HORIZON THERAPEUTICS, LLC v. LUPIN LTD. et al |
1:16-cv-04438 |
D.N.J. |
|
|
|
|
68 |
HORIZON THERAPEUTICS, LLC v. LUPIN LTD. et al |
1:16-cv-04438 |
D.N.J. |
|
|
|
|
69 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
70 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
71 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
72 |
ViiV Healthcare Company et al v. Lupin Limited et al |
1:17-cv-01576 |
D.Del. |
|
|
|
|
73 |
ViiV Healthcare Company et al v. Lupin Limited et al |
1:17-cv-01576 |
D.Del. |
|
|
|
|
74 |
ViiV Healthcare Company et al v. Lupin Limited et al |
1:17-cv-01576 |
D.Del. |
|
|
|
|
75 |
Anacor Pharmaceuticals, Inc. v. Lupin Limited et al |
1:18-cv-01606 |
D.Del. |
|
|
|
|
76 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
77 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
78 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
79 |
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Lupin Atlantis Holdings SA et al |
1:20-cv-00697 |
D.Del. |
|
|
|
|
80 |
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Lupin Atlantis Holdings SA et al |
1:20-cv-00697 |
D.Del. |
|
|
|
|
81 |
Vertex Pharmaceuticals Incorporated v. Lupin Limited et al |
1:23-cv-00581 |
D.Del. |
|
|
|
|
82 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
83 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
84 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
85 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
86 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
87 |
Aventis Pharma Deutschland GMBH et al v. Lupin Ltd. et al |
2:05-cv-00421 |
E.D.Va. |
|
|
|
|
88 |
Aventis Pharma Deutschland GMBH et al v. Lupin Ltd. et al |
2:05-cv-00421 |
E.D.Va. |
|
|
|
|
89 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. LUPIN LIMITED et al |
2:07-cv-00247 |
D.N.J. |
|
|
|
|
90 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. LUPIN LIMITED et al |
2:07-cv-00247 |
D.N.J. |
|
|
|
|
91 |
ABBOTT LABORATORIES et al v. LUPIN LIMITED et al |
2:09-cv-01007 |
D.N.J. |
|
|
|
|
92 |
ABBOTT LABORATORIES et al v. LUPIN LIMITED et al |
2:09-cv-01007 |
D.N.J. |
|
|
|
|
93 |
TEVA WOMEN'S HEALTH, INC. v. LUPIN, LTD. et al |
2:10-cv-00080 |
D.N.J. |
|
|
|
|
94 |
ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. v. LUPIN PHARMACEUTICALS, INC. et al |
2:10-cv-00322 |
D.N.J. |
|
|
|
|
95 |
ROCHE PALO ALTO LLC et al v. LUPIN PHARMACEUTICALS, INC. et al |
2:10-cv-03561 |
D.N.J. |
|
|
|
|
96 |
ROCHE PALO ALTO LLC et al v. LUPIN PHARMACEUTICALS, INC. et al |
2:10-cv-03561 |
D.N.J. |
|
|
|
|
97 |
ROCHE PALO ALTO LLC et al v. LUPIN PHARMACEUTICALS, INC. et al |
2:10-cv-03561 |
D.N.J. |
|
|
|
|
98 |
THE UNITED STATES OF AMERICA et al v. LUPIN LIMITED |
2:11-cv-03995 |
D.N.J. |
|
- 6 University/Government/Non-profit
|
|
|
99 |
THE UNITED STATES OF AMERICA et al v. LUPIN LIMITED |
2:11-cv-03995 |
D.N.J. |
|
- 6 University/Government/Non-profit
|
|
|
100 |
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al |
2:12-cv-05358 |
D.N.J. |
|
|
|
|